Thomas G. Cotter, MD MS
@TCotterMD
Followers
3K
Following
3K
Media
144
Statuses
1K
Transplant & General Hepatologist @UTSWMedCenter & Moncrief Medical Center Fort Worth – Clinician Scientist & Trialist advancing liver and metabolic health
Dallas, TX
Joined February 2011
How Much #Alcohol Is Bad For The #Liver? A common & important question!Time for a #livertwitter #medtwitter #tweetorial Aims: -Measure Alcohol Content -Understand Alcohol Metabolism -Examine Pathophysiology of Alcohol-Associated Liver Disease -Ascertain “Safe” Alcohol Intake
11
62
204
Future gastroenterologists from the MWHC family are in Phoenix! 😇☀️ #GITwitter @AmCollegeGastro @IMMWHC #ACG2025
1
4
32
⚡ Join the #HepMadness! Exceptional liver articles from our very own @LtxJournal and @HepCommJournal are going head-to-head — tournament style. Submit your bracket to compete by Friday, Oct. 31, at 5 p.m. ET, and see who will come out on top. @LiverFellow
https://t.co/Xaeb2dJ9HH
0
13
23
Thanks @VUMChealth @VUMCDiscoveries for highlighting our multidisciplinary study! We are thrilled for this milestone in the quest to explore #CirrhoticCardiomyopathy, its natural course and mechanisms over the next 5 years. Excited to work with my amazing collaborators
news.vumc.org
Study to explore cirrhotic cardiomyopathy in patients with decompensated cirrhosis (severe liver disease) and liver transplant recipients.
3
4
16
A real honor to host Dr Anna Mae Diehl from @DukeU at @VCU_Liver Research Seminars… “Fixing Fatty Livers” such an inspiring talk from a brilliant scientist #LiverX
2
3
47
📢 The wait is over — regular abstracts are NOW LIVE! View the science and breakthrough research being presented at #TLM25. Start planning your schedule today @AASLDtweets @LiverFellow. 🔗 https://t.co/dhJoRaBdlD
1
2
19
Trailblazer @DrGlendaRamos — 2025 @myESMO Oncologist of the Year ✅1st female oncologist in 🇪🇨 ✅Medicine Chief @SolcaGuayaquil ✅ 30+ yrs advancing cancer care & training ✅Medication access champion ✅”Don’t Give Cancer a Chance” campaign ✅National media 🗞️ @eluniversocom
3
4
21
I am so incredibly proud of my mother @DrGlendaRamos for receiving the inaugural oncologist of the year award #ESMO2025 highlighting her impact in #Ecuador and her relentless fight to improve access to care and medicines for patients, mentorship to trainees and medical education
#ESMO25: Glenda Ramos Martínez receives the first ESMO Oncologist of the Year Award for her pioneering role as the first female medical oncologist in Ecuador and outstanding advocacy to improve access to #CancerTreatments
#ESMODailyReporter👉 https://t.co/hggddTjiYk
2
1
6
Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction-Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide
diabetesjournals.org
OBJECTIVE. To explore the relationship between metabolic and histological responses in a phase 2 trial of tirzepatide in metabolic dysfunction–associated s
0
5
31
#ESMO25: Glenda Ramos Martínez receives the first ESMO Oncologist of the Year Award for her pioneering role as the first female medical oncologist in Ecuador and outstanding advocacy to improve access to #CancerTreatments
#ESMODailyReporter👉 https://t.co/hggddTjiYk
2
3
12
We are so proud of your contributions @MonicaTincopa !
Honored to be supported by @AmCollegeGastro for our important work towards #HealthEquity for the #Hispanic #Latino community with chronic #liver disease @MASLDResearch @DrLoomba @UCSDHealth
1
2
18
Honored to be supported by @AmCollegeGastro for our important work towards #HealthEquity for the #Hispanic #Latino community with chronic #liver disease @MASLDResearch @DrLoomba @UCSDHealth
#HispanicHeritageMonth Spotlight: Monica A. Tincopa, MD Dr. Tincopa is recognized for her professional achievements and unwavering dedication to diversity, culturally informed care, and health equity in gastroenterology and hepatology. ➡️ https://t.co/r5mdv9xwQe
#DiversityinGI
1
3
19
Proud to support Elias Rady’s #Match2026 IM application. He’s been the main driver of the Dallas Dionysus Study, pairs outstanding Step scores with strong clinical and research skills, and is destined to be an early pick in the 2026 IM Match Draft 📚🏆🏈
Hi #MedTwitter! I’m Elias Rady, an @AUB_Lebanon graduate and current postdoctoral research fellow @UTSWMedCenter. Interested in Hepatology and academic medicine. I’m thrilled to be applying for #InternalMedicine #Match2026. AAMC ID: 16731155
1
1
50
That’s a wrap (2 days late) on our 2025 Chicago Cholangiocarcinoma Symposium - fantastic collaboration of science and advocacy to bring inspiration and hope to our patients. Especially proud of our multiD team @curecc @UChicagoMed @UChicagoGI
0
1
22
The first GLP-1 medicine, twice daily exenatide was approved April 28 2005. Several decades later, the pace of innovation is expanding rapidly, encompassing new medicines and receptors, unique delivery options, and expanding therapeutic indications
jamanetwork.com
This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.
5
48
216
Grateful to be on this phenomenal review! Thank you for all your help @TCotterMD for getting this over the line!
Great to see our @NIAAAnews-funded INTEGRATE Study Group work on early liver transplantation in ALD published in @LTxJournal. Privileged to collaborate with leaders @LisaVWMD, @elizabeth_verna, David Goldberg & Jessica Mellinger. Much more to come! 🔗
1
1
8
Got a belly full of tense ascites? Interested to know how fast you will lose weight if you cut the sodium out of your diet? (hint: how fast does the peritoneum absorb fluid?) #cirrhosis #livertwitter #ThankYouInterLibraryLoan
5
26
137
Great to see our @NIAAAnews-funded INTEGRATE Study Group work on early liver transplantation in ALD published in @LTxJournal. Privileged to collaborate with leaders @LisaVWMD, @elizabeth_verna, David Goldberg & Jessica Mellinger. Much more to come! 🔗
journals.lww.com
d alcohol use, particularly among patients in early adulthood, and exacerbated by the COVID-19 pandemic, has led to an increased demand for eLT for ALD. Recent studies have demonstrated that eLT can...
0
4
21